Jubilant Pharmova arm gets OAI status from USFDA for Montreal facility
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Stay updated with breaking news from Solid Dosage Formulations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
/PRNewswire/ -- Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly...
Jubilant Biosys and Yale University announce collaboration to accelerate multiple small molecule discovery programs News provided by Share this article Share this article NEW HAVEN, Conn. and BENGALURU, India, Feb. 9, 2021 /PRNewswire/ -- Today, Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs. Under the scope of this partnership, Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets. Areas of collaboration include medicinal chemistry, structural biology, ...